Research Grants

Dedicated to driving scientific progress and empowering visionary researchers and academics worldwide, the ICPO Foundation is powered by generous philanthropic contributions and patient donations. Through ICPO research grants specifically tailored to the dynamic field of Radiotheranostics, we facilitate groundbreaking advancements in healthcare. Guided by the expertise of our esteemed Scientific Advisory Board, chaired by Professor Richard P. Baum and comprising over 15 leading experts worldwide, ICPO carefully selects and supports exciting research projects from the start to finish.

 

Every application undergoes thorough evaluation by our Scientific Advisory Board, with funding approvals granted quarterly. We focus exclusively on projects within the scientific realm of Radiotheranostics and extend our support globally, encouraging academic breakthroughs and shaping the future of healthcare standards and innovation on a significant scale. Join us in pioneering the future of healthcare.

 

For application and more information please contact:

 

Karim Bouterfa
International Expansion Project Manager

karim.bouterfa@icpo.foundation

ICPO is pleased to support and fund academic research in Radiotheranostics, made possible by the generous donations from patients. Through ICPO Research Grants, we provide vital seed funding for projects led by emerging talents, paving the way for their growth in new career paths within the field of Radiotheranostics. In applying for an ICPO Grant via our application form, you will provide us with a detailed description of your project and a breakdown of costs.

 

Additionally, you will ensure to include official documentation verifying your affiliation with a public institution. Kindly note that ICPO does not fund purchases of medical equipment. Our focus remains dedicated to supporting research activities related to Radiotheranostics. Rest assured, your application will undergo thorough review by our esteemed Scientific Advisory Board, comprising over 15 international experts in Radiomolecular Precision Oncology. Please find below some examples of our ICPO Grants.


Illustration of a few projects funded by ICPO Research Grants

Investigation of 161Tb-based PSMA radioligand therapy: efficacy and safety evaluation in clinically relevant mouse models

PSI Paul Scherrer Institut – Dr. Korbinian Krieger and PhD Cristina Müller


Development of 18F-labeled radioligands for PET imaging of PD-L1 positive tumors

Helmholtz-Zentrum Dresden – Prof. Dr. Klaus Kopka & Dr. Sven Stadlbauer


FAP Theranostics- Cancer-Associated Fibroblasts (CAFs)-Targeted Imaging and Therapy and Combination with Immunotherapy or Chemotherapy (including also other radioligands)

Dr. Jingjing Zhang &  Vivianne Jakobsson